Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kania Edwin M Jr
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   11,445,835    

Indirect Shares

   62,961,806      
Direct Value   $119,494,044    

Indirect Value

   $173,648,624      
Total Shares   74,407,641      
Total Value   $293,142,667      


Exact Sciences Corp $9,589,442 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,872,072 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,036,035 Editas Medicine, Inc. $15,783,902 Quanterix Corp $34,234,146 Moderna, Inc. $0 Transmedics Group, Inc. $34,058,926 Exact Sciences Corp $9,589,442 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,872,072 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,036,035 Editas Medicine, Inc. $15,783,902 Quanterix Corp $34,234,146 Moderna, Inc. $0 Transmedics Group, Inc. $34,058,926
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   115.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Exact Sciences Corp EXAS Director 2009-07-20 172,503 2009-07-20 1,202,787    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH 10% Owner 2013-03-25 1,165,786 2013-03-25 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2014-12-23 28,734 2014-12-23 544,055    Premium*  
            DNIB Upwind Inc BIND 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 2016-09-23 1,940,589 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2014-02-19 656,490 0    Premium*  
            T2 Biosystems, Inc. TTOO 10% Owner 2014-08-12 0 2014-08-12 2,374,571    Premium*  
            Bg Medicine, Inc. BGMD 10% Owner 2014-12-04 0 2014-12-11 4,915,402    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 0 2016-05-25 0    Premium*  
            Selecta Biosciences Inc SELB Director 2017-05-16 26,528 2017-05-16 560,067    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2017-08-17 2,378,663 2017-08-17 262,386    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-11 2,764,256 2016-08-11 45,422    Premium*  
            Quanterix Corp QTRX 10% Owner 2017-12-11 2,030,495 2017-12-11 0    Premium*  
            Evelo Biosciences Inc EVLO 10% Owner 2018-05-11 0 2018-05-11 18,233,403    Premium*  
            Rubius Therapeutics, Inc. RUBY 10% Owner 2018-07-20 0 2018-07-20 7,563,703    Premium*  
            Moderna, Inc. MRNA 10% Owner 2020-01-14 23,847 2019-12-11 20,253,972    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2019-03-04 2,682,840    Premium*  
            Transmedics Group, Inc. TMDX 2023-05-25 257,944 2023-05-25 46,142    Premium*  
            Axcella Health Inc. AXLA 10% Owner 0 2019-05-08 2,714,440    Premium*  
* Premium Members only  

Records found :    78         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XLRN Acceleron Pharma Inc Director   –       •      –    2013-09-18 3 IO $0.00 $0 D/D 0 4,867 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-05 3 IO $0.00 $0 D/D 0 419,852 -
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-12 3 IO $0.00 $0 D/D 0 32,508 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2015-06-25 3 IO $0.00 $0 I/I 0 3,055,556 -
SELB Selecta Biosciences Inc Director   –       •       •   2016-06-21 3 IO $0.00 $0 I/I 0 31,115 -
SYRS Syros Pharmaceuticals, In... 10% Owner   –       –       •   2016-06-29 3 IO $0.00 $0 I/I 0 213,332 -
KLDO Kaleido Biosciences, Inc. 10% Owner   –       –       •   2019-02-27 3 IO $0.00 $0 I/I 0 1,735,729 -
TMDX Transmedics Group, Inc. Director   –       •      –    2019-05-01 3 IO $0.00 $0 I/I 0 370,831 -
AXLA Axcella Health Inc. 10% Owner   –       –       •   2019-05-08 3 IO $0.00 $0 I/I 0 2,714,440 -
EXAS Exact Sciences Corp Director   –       •      –    2005-10-26 4 A $2.08 $9,999 D/D 4,807 82,036 -
EXAS Exact Sciences Corp Director   –       •      –    2006-07-21 4 A $2.09 $9,999 D/D 4,784 86,820 -
EXAS Exact Sciences Corp Director   –       •      –    2007-08-10 4 A $3.00 $30,000 D/D 10,000 96,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2008-07-18 4 A $0.71 $7,100 D/D 10,000 106,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-01-02 4 A $0.00 $0 D/D 60,344 167,164 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-07-20 4 A $0.00 $0 D/D 5,339 172,503 0 -
TTPH Tetraphase Pharmaceutical... 10% Owner   –       –       •   2013-03-25 4 B $7.00 $3,442,768 D/D 491,824 1,165,786 2.45 -
TTPH Tetraphase Pharmaceutical... 10% Owner   –       –       •   2013-03-25 4 A $0.00 $0 D/D 1,565,849 673,962 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2013-09-24 4 A $0.00 $0 I/I 2,276,479 2,281,346 0 -
BIND DNIB Upwind Inc 10% Owner   –       –       •   2013-09-25 4 A $0.00 $0 I/I 1,542,616 1,542,616 0 -
BIND DNIB Upwind Inc 10% Owner   –       –       •   2013-09-25 4 B $15.00 $300,000 I/I 20,000 1,562,616 1.5 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-11 4 B $10.00 $3,787,290 D/D 378,729 293,268 2.45 -
CARM Carisma Therapeutics Inc 10% Owner   –       –       •   2014-02-11 4 A $0.00 $0 D/D 2,574,844 260,356 0 -
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-19 4 A $0.00 $0 D/D 623,982 656,490 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-04-22 4 AS $35.89 $4,367,167 I/I (121,682) 122,823 0 -
XLRN Acceleron Pharma Inc Director   –       •      –    2014-04-23 4 AS $33.81 $801,297 I/I (23,700) 121,472 0 -
  78  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us